Ortho Clinical Diagnostics Holdings plc Ordinary Shares
OCDX
OCDX was delisted on the 26th of May, 2022.
1 hedge funds and large institutions have $1K invested in Ortho Clinical Diagnostics Holdings plc Ordinary Shares in 2022 Q2 according to their latest regulatory filings, with 0 funds opening new positions, 0 increasing their positions, 0 reducing their positions, and 166 closing their positions.
98.75% less ownership
Funds ownership: 98.75% → 0% (-99%)
99% less funds holding
Funds holding: 170 → 1 (-169)
100% less funds holding in top 10
Funds holding in top 10: 4 → 0 (-4)
100% less capital inflows, than outflows
Capital inflows: $0 | Capital outflows: $4.36B
100% less first-time investments, than exits
New positions opened: 0 | Existing positions closed: 166
Top Buyers
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Carlyle Group
Washington,
District of Columbia
|
-$2.2B |
| 2 |
T. Rowe Price Associates
Baltimore,
Maryland
|
-$364M |
| 3 |
Vanguard Group
Malvern,
Pennsylvania
|
-$206M |
| 4 |
BlackRock
New York
|
-$160M |
| 5 |
JP Morgan Chase
New York
|
-$159M |
OCDX Hedge Fund Activity: Q2 2022 in Review
1 of the 5,963 institutional investors tracked by Wall St. Rank reported a position in Ortho Clinical Diagnostics Holdings plc Ordinary Shares (OCDX) for Q2 2022, worth a combined $1K — down 100% from $4.38B a quarter earlier.
Sellers outnumbered buyers: 166 funds closed out of OCDX and 0 opened new positions — a net loss of 166 holders — while 0 trimmed existing stakes and 0 added.
The largest seller was Carlyle Group, exiting entirely with an estimated $2.2B sold.
- 1 institutional investor held Ortho Clinical Diagnostics Holdings plc Ordinary Shares (OCDX) as of Q2 2022, down from 170 in Q1 2022.
- Funds reported $1K of Ortho Clinical Diagnostics Holdings plc Ordinary Shares stock for Q2 2022, down 100% quarter-over-quarter.
- 0 funds opened new Ortho Clinical Diagnostics Holdings plc Ordinary Shares positions in Q2 2022 and 166 closed out, a net change of -166 holders.
- The largest Ortho Clinical Diagnostics Holdings plc Ordinary Shares seller in Q2 2022 was Carlyle Group, an estimated $2.2B sold.
Based on aggregated 13F filings for Q2 2022.